Characterization of a novel K+ channel activator, EMD 52962, in electrophysiological and pharmacological experiments.
Pharmaceutical Research Department, E Merck, Darmstadt, FRG.
J E
JE
De Peyer
I
I
Lues
R
R
Gericke
G
G
Häusler
D000818:Animals; D001578:Benzopyrans / Q000494:pharmacology*; D004095:Dihydropyridines / Q000494:pharmacology*; D004594:Electrophysiology; D066298:In Vitro Techniques; D009131:Muscle, Smooth, Vascular / Q000187:drug effects* / Q000502:physiology; D015221:Potassium Channels / Q000187:drug effects* / Q000502:physiology; D014665:Vasodilator Agents / Q000494:pharmacology*
D001578:Benzopyrans; D004095:Dihydropyridines; D015221:Potassium Channels; D014665:Vasodilator Agents; C061050:bimakalim